Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

BACKGROUND & AIMS Bariatric procedures, such as Roux-en-Y gastric bypass (RYGB) or vertical sleeve gastrectomy (VSG), are the most effective approaches to resolve type 2 diabetes in obese individuals. Alimentary glucose absorption and intestinal disposal of blood glucose have not been directly compared between individuals or animals that underwent RYGB vs VSG. We evaluated in rats and humans how the gut epithelium adapts after surgery and the consequences on alimentary glucose absorption and intestinal disposal of blood glucose. METHODS Obese male rats underwent RYGB, VSG, or sham (control) operations. We collected intestine segments from all rats; we performed histologic analyses and measured levels of messenger RNAs encoding the sugar transporters SGLT1, GLUT1, GLUT2, GLUT3, GLUT4, and GLUT5. Glucose transport and consumption were assayed using ex vivo jejunal loops. Histologic analyses were also performed on Roux limb sections from patients who underwent RYGB 1-5 years after surgery. Roux limb glucose consumption was assayed after surgery by positron emission and computed tomography imaging. RESULTS In rats and humans that underwent RYGB, the Roux limb became hyperplasic, with an increased number of incretin-producing cells compared with the corresponding jejunal segment of controls. Furthermore, expression of sugar transporters and hypoxia-related genes increased and the nonintestinal glucose transporter GLUT1 appeared at the basolateral membrane of enterocytes. Ingested and circulating glucose was trapped within the intestinal epithelial cells of rats and humans that underwent RYGB. By contrast, there was no hyperplasia of the intestine after VSG, but the intestinal absorption of alimentary glucose was reduced and density of endocrine cells secreting glucagon-like peptide-1 increased. CONCLUSIONS The intestine adapts differently to RYGB vs VSG. RYGB increases intestinal glucose disposal and VSG delays glucose absorption; both contribute to observed improvements in glycemia.

[1]  L. Groop,et al.  Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[2]  J. Holst,et al.  Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes , 2015, Diabetologia.

[3]  M. le Gall,et al.  Remodeling of the Residual Gastric Mucosa after Roux-En-Y Gastric Bypass or Vertical Sleeve Gastrectomy in Diet-Induced Obese Rats , 2015, PloS one.

[4]  R. Seeley,et al.  The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. , 2015, Cell metabolism.

[5]  Amanda Jiménez,et al.  Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile. , 2015, Annals of surgery.

[6]  H. Berthoud,et al.  Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats , 2015, Obesity Surgery.

[7]  A. Tavakkoli,et al.  Insulin Cessation and Diabetes Remission After Bariatric Surgery in Adults With Insulin-Treated Type 2 Diabetes , 2015, Diabetes Care.

[8]  M. Horowitz,et al.  Upregulation of intestinal glucose transporters after Roux‐en‐Y gastric bypass to prevent carbohydrate malabsorption , 2014, Obesity.

[9]  S. Luquet,et al.  Intestinal deletion of leptin signaling alters activity of nutrient transporters and delayed the onset of obesity in mice , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  S. Ashley,et al.  Intestinal sweet-sensing pathways and metabolic changes after Roux-en-Y gastric bypass surgery. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[11]  T. Sweeney,et al.  Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. , 2014, Best practice & research. Clinical gastroenterology.

[12]  D. D’Alessio,et al.  Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery , 2014, Reviews in Endocrine and Metabolic Disorders.

[13]  H. Pijl,et al.  Calorie Restriction is a Major Determinant of the Short‐Term Metabolic Effects of Gastric Bypass Surgery in Obese Type 2 Diabetic Patients , 2014, Clinical endocrinology.

[14]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.

[15]  S. Woods,et al.  Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy. , 2014, American journal of physiology. Endocrinology and metabolism.

[16]  J. Holst Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. , 2013, Current opinion in pharmacology.

[17]  N. Stylopoulos,et al.  Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass , 2013, Science.

[18]  J. Jelsing,et al.  Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats , 2013, PloS one.

[19]  D. Drucker,et al.  Pharmacology, physiology, and mechanisms of incretin hormone action. , 2013, Cell metabolism.

[20]  M. Horowitz,et al.  Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones , 2013, Diabetes Care.

[21]  L. Szablewski Expression of glucose transporters in cancers. , 2013, Biochimica et biophysica acta.

[22]  E. Livingston,et al.  Rapid Improvement in Diabetes After Gastric Bypass Surgery , 2013, Diabetes Care.

[23]  C. L. le Roux,et al.  Influence of diabetes surgery on gut hormones and incretins. , 2013, Nutricion hospitalaria.

[24]  H. Berthoud,et al.  Roux‐en‐Y gastric bypass surgery increases number but not density of CCK‐, GLP‐1‐, 5‐HT‐, and neurotensin‐expressing enteroendocrine cells in rats , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[25]  D. Sandoval,et al.  Bariatric surgeries: beyond restriction and malabsorption , 2011, International Journal of Obesity.

[26]  S. Woods,et al.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. , 2011, Gastroenterology.

[27]  S. Bloom,et al.  Remission of Type 2 Diabetes After Gastric Bypass and Banding: Mechanisms and 2 Year Outcomes , 2010, Annals of surgery.

[28]  Elizabeth A. Odstrcil,et al.  The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. , 2010, The American journal of clinical nutrition.

[29]  S. Bloom,et al.  Gastric bypass increases energy expenditure in rats. , 2010, Gastroenterology.

[30]  L. Wallace,et al.  The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. , 2010, Journal of pediatric surgery.

[31]  N. Abumrad,et al.  The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery , 2010, Diabetes Care.

[32]  Francesco Rubino,et al.  Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. , 2010, Annual review of medicine.

[33]  G. Mingrone,et al.  Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. , 2009, Diabetes & metabolism.

[34]  A. Tavakkolizadeh,et al.  Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[35]  F. Ismail-Beigi,et al.  Regulation of glut1 mRNA by Hypoxia-inducible Factor-1 , 2001, The Journal of Biological Chemistry.

[36]  B. Thorens Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. , 1996, The American journal of physiology.

[37]  B. Ebert,et al.  Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*) , 1995, The Journal of Biological Chemistry.

[38]  J. Argilés,et al.  Intestinal handling of a glucose gavage by the rat , 1992, Molecular and Cellular Biochemistry.